Clinical Trials in Orbassano, TO
15 recruiting
Showing 1–15 of 15 trials
Recruiting
Phase 1Phase 2
An Open-label Dose Escalation and Expansion, Followed by a Phase II Study of Tulmimetostat (DZR123) and JSB462 (Luxdegalutamide) in Patients With Progressive Metastatic Castrate Resistant Prostate Cancer (mCRPC) (TulmiSTAR-01)
Progressive Metastatic Castrate Resistant Prostate Cancer
Novartis Pharmaceuticals188 enrolled30 locationsNCT07206056
Recruiting
Phase 3
A Study to Investigate the Efficacy, Safety and Tolerability of Remibrutinib Versus Placebo in Adult Patients With Generalized Myasthenia Gravis
Generalized Myasthenia Gravis
Novartis Pharmaceuticals180 enrolled100 locationsNCT06744920
Recruiting
Phase 3
A Phase III Study to Investigate Efficacy, Safety and Tolerability of Iptacopan Compared With Placebo in Participants Aged 18 to 85 Years With gMG.
Generalized Myasthenia Gravis
Novartis Pharmaceuticals146 enrolled112 locationsNCT06517758
Recruiting
Phase 2
An Open-label Study of JSB462 (Luxdegalutamide) in Combination With Abiraterone in Adult Male Patients With Metastatic Hormone-sensitive Prostate Cancer (mHSPC)
Metastatic Hormone Sensitive Prostate Cancer
Novartis Pharmaceuticals150 enrolled65 locationsNCT06991556
Recruiting
Investigation of REcurrence Mechanisms to Adjuvant osimertINib in Radically Resected EGFR-mutated NSCLC Patients
EGFR-mutated NSCLC
Gruppo Oncologico Italiano di Ricerca Clinica100 enrolled25 locationsNCT07363252
Recruiting
Phase 4
Rollover Study for Patients With Sickle Cell Disease Who Have Completed a Prior Novartis-Sponsored Crizanlizumab Study
Sickle Cell Disease
Novartis Pharmaceuticals130 enrolled30 locationsNCT04657822
Recruiting
Phase 2
A Study to Determine the Efficacy and Safety of Luspatercept in Adult Participants and to Evaluate the Safety and Pharmacokinetics in and Adolescent Participants With Alpha (α)-Thalassemia
Anemia
Bristol-Myers Squibb189 enrolled36 locationsNCT05664737
Recruiting
The Italian Transthyretin Amyloidosis Web-Network
ATTR Amyloidosis
Fondazione IRCCS Policlinico San Matteo di Pavia1,000 enrolled30 locationsNCT05444920
Recruiting
Observational, Prospective, Multi-centric Study Exploring HER2 Mutations Incidence and Therapeutic Management in aNSCLC
HER2NSCLC (Advanced Non-small Cell Lung Cancer)
Gruppo Oncologico Italiano di Ricerca Clinica50 enrolled22 locationsNCT07356544
Recruiting
A Retrospective Protocol Empowering Precision Research in Colorectal Cancer (ALFAOMEGA-RETRÒ)
Colorectal, Cancer
IFOM ETS - The AIRC Institute of Molecular Oncology500 enrolled13 locationsNCT05101382
Recruiting
International obServational sTudy on AiRway manaGement in operAting Room and Non-operaTing Room anaEsthesia
Airway Complication of Anesthesia
University of Turin, Italy10,500 enrolled10 locationsNCT05759299
Recruiting
Phase 2
Durvalumab With Carboplatin and Etoposide Chemotherapy in Pulmonary Large-cell Neuroendocrine Carcinoma (LCNEC)
Pulmonary Large-cell Neuroendocrine Carcinoma
Gruppo Oncologico Italiano di Ricerca Clinica49 enrolled15 locationsNCT06418087
Recruiting
LOWER: Lomitapide Observational Worldwide Evaluation Registry
Homozygous Familial Hypercholesterolemia
Amryt Pharma300 enrolled75 locationsNCT02135705
Recruiting
BRING-UP 3 Heart Failure
Heart Failure
Heart Care Foundation10,000 enrolled187 locationsNCT06279988
Recruiting
BRING-UP Prevention
Peripheral Arterial DiseaseCerebrovascular DisordersIschemic Heart Disease
Heart Care Foundation6,000 enrolled196 locationsNCT06275113